AMED:F:F-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 304.4

Change

-1.35 (-0.44)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.01 (-0.03%)

USD 115.48B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 88.54B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.03 (+0.12%)

USD 75.49B
EUNL:F iShares Core MSCI World UCITS ..

-0.24 (-0.25%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.15 (-0.07%)

USD 56.16B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.01 (+0.05%)

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.05 (-0.05%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.09 (+0.09%)

USD 51.63B

ETFs Containing AMED:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.55% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.55% 64% D 59% D-
Trailing 12 Months  
Capital Gain 16.18% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.18% 63% D 60% D-
Trailing 5 Years  
Capital Gain 53.07% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.07% 69% C- 55% F
Average Annual (5 Year Horizon)  
Capital Gain 8.97% 78% C+ 73% C
Dividend Return 8.97% 76% C+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.80% 35% F 69% C-
Risk Adjusted Return 56.76% 80% B- 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.